Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.14
Delayed Data
As of Dec 02
 -0.0026 / -1.82%
Today’s Change
0.11
Today|||52-Week Range
0.42
-65.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues2.2M5.2M3.3M2.7M
 
 
 
 
 
Cost of Goods Sold835.7K1.0M2.0M1.7M
 
 
 
 
 
Depreciation And Amortization166.8K173.0K172.5K165.8K
 
 
 
 
 
 
Operating ExpensesGross Income1.2M4.0M1.1M813.9K
 
 
 
 
 
General Expenses3.9M3.4M2.3M2.0M
 
 
 
 
 
Research And Development3.2M2.4M1.6M1.3M
 
 
 
 
 
Total Operating Expenses4.9M4.6M4.5M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M569.8K-1.2M-1.2M
 
 
 
 
 
Extraordinary Credit0.007.5M2.4M5.5M
 
 
 
 
Extraordinary Charge-9.5M0.000.000.00
 
 
Interest Expense On Debt68.1K85.8K68.9K57.4K
 
 
 
 
 
Other Expenses0.002.8K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.2M8.0M1.1M4.2M
 
 
 
 
 
Income Taxes0.00-520.5K-2.5K0.00
 
 
 
Net Income-37.0M22.6M-1.0M27.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS684.8M711.4M722.8M806.9M
 
 
 
 
 
Shares To Calculate EPS Diluted836.5M711.4M722.8M816.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05$0.00$0.00$0.00
 
 
EPS Diluted-$0.05$0.03-$0.00-$0.00